Merck’s soft guidance overshadows quarterly beat to send stock down 8%

Published on:

February 4, 2025

[ad_1]

Merck’s stock tumbled 6% early Tuesday, after the drug company’s softer-than-expected guidance for the current year offset better-than-expected fourth-quarter earnings.

[ad_2]

Source link

Leave a Reply Cancel reply

Please enter your comment!

Please enter your name here

You have entered an incorrect email address!

Please enter your email address here

WorldDesk https://news.projectliberte.io

Subscribe now

To access premium content

BLAST Premier 2022 – Betting Tips and Schedule

Is Overwatch League Getting Outsourced A Good Thing?

The Battle of The Metaverse is Just Getting Started

Vulcan Scholarships, Town Star Nodes, The Sandbox Alpha Event

The Galaxy of Lemuria Review – Play To Earn MMORPG

BLAST Premier 2022 – Betting Tips and Schedule

Zendodo Party Review: Where NFTs Meets DeFi on WAX

Genesis Worlds Metaverse Review – A 100 Years Project

Non-Fungible: A Play-To-Earn Substances Selling Game

Genesis Worlds Interview With CEO Jason Cassidy

Dreamverse NFT Festival: Interview With Twobadour

Inside Axie Infinity With Jihoz – Growth Lead

Alien Worlds Interview With Co-Founder Saro Mckenna

Talking Hash Rush With CMO Alexander Benitez & CM

Merck’s soft guidance overshadows quarterly beat to send stock down 8%

Related

CFTC Staff Seek Public Comment Regarding Perpetual Contracts in Derivatives Markets

Nasdaq-listed Upexi shares up 630% after $100M raise, SOL treasury

How Meta’s News Ban Could Disrupt Canada’s Election

‘She’s kept him afloat’: I’m 78 and leaving my daughter, 41, my life savings, but her partner doesn’t pay rent. What do I do?

SPX, DXY, BTC, ETH, XRP, BNB, SOL, DOGE, ADA, LINK

2010-22398 | CFTC

Overly bearish investors risk writing off 2025 too soon. These strategies offer upside and downside protection.

Leave a Reply Cancel reply